Evolus, Inc. (EOLS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1237907,
    "name": "Evolus, Inc.",
    "stock_name": "Evolus, Inc.",
    "full_name": "Evolus, Inc.",
    "name_url": "stocks-analysis/evolus-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "6.81",
    "chg": 0.29,
    "chgp": "4.45%",
    "dir": 1,
    "prev_price": "6.52",
    "mcapval": "492.26",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US30052C1071",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.08 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/evolus-inc-1237907-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Evolus, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-evolus-inc-technically-bullish-or-bearish-3546058",
        "imagepath": "",
        "date": "2025-09-20 19:24:03",
        "description": "As of 5 August 2025, the technical trend for Evolus, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators supporting this view including bearish MACD readings on both weekly and monthly time frames, bearish Bollinger Bands, and a bearish daily moving average. The KST is also bearish on both weekly and monthly levels, while the Dow Theory indicates a mildly bearish stance on the weekly chart. Additionally, the stock has underperformed significantly against the S&P 500 across multiple periods, with a year-to-date return of -41.85% compared to the S&P 500's 12.22%...."
      },
      {
        "title": "Is Evolus, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-evolus-inc-overvalued-or-undervalued-3542688",
        "imagepath": "",
        "date": "2025-09-20 17:59:27",
        "description": "As of 12 August 2019, the valuation grade for Evolus, Inc. moved from does not qualify to risky, indicating a significant shift in its financial standing. The company appears to be overvalued, particularly given its troubling financial metrics, including a Price to Book Value of -98.02, an EV to EBIT of -19.61, and an EV to EBITDA of -23.65. These ratios suggest that the company's valuation is not supported by its financial performance.\n\nIn comparison to its peers, Evolus, Inc. has a P/E ratio of -8.2365, while PetIQ, Inc. holds a fair valuation with a P/E ratio of 27.1022, highlighting a stark contrast in market perception. Additionally, Repare Therapeutics, Inc. does not qualify for a valuation, further emphasizing the challenges Evolus faces in its industry. Over the past year, Evolus has underperformed significantly, with a stock return of -60.42% compared to the S&P 500's return of 17.14%, reinforcing ..."
      }
    ],
    "total": 7,
    "sid": "1237907",
    "stock_news_url": "https://www.marketsmojo.com/news/evolus-inc-1237907"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Evolus, Inc. technically bullish or bearish?

2025-09-20 19:24:03

As of 5 August 2025, the technical trend for Evolus, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators supporting this view including bearish MACD readings on both weekly and monthly time frames, bearish Bollinger Bands, and a bearish daily moving average. The KST is also bearish on both weekly and monthly levels, while the Dow Theory indicates a mildly bearish stance on the weekly chart. Additionally, the stock has underperformed significantly against the S&P 500 across multiple periods, with a year-to-date return of -41.85% compared to the S&P 500's 12.22%....

Is Evolus, Inc. overvalued or undervalued?

2025-09-20 17:59:27

As of 12 August 2019, the valuation grade for Evolus, Inc. moved from does not qualify to risky, indicating a significant shift in its financial standing. The company appears to be overvalued, particularly given its troubling financial metrics, including a Price to Book Value of -98.02, an EV to EBIT of -19.61, and an EV to EBITDA of -23.65. These ratios suggest that the company's valuation is not supported by its financial performance. In comparison to its peers, Evolus, Inc. has a P/E ratio of -8.2365, while PetIQ, Inc. holds a fair valuation with a P/E ratio of 27.1022, highlighting a stark contrast in market perception. Additionally, Repare Therapeutics, Inc. does not qualify for a valuation, further emphasizing the challenges Evolus faces in its industry. Over the past year, Evolus has underperformed significantly, with a stock return of -60.42% compared to the S&P 500's return of 17.14%, reinforcing ...

View All News